NYSE International 100
7.594,38
PKT
+58,88
PKT
+0,78
%
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.10.24 | TotalEnergies Neutral | Goldman Sachs Group Inc. | |
| 31.10.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 31.10.24 | AXA Neutral | Goldman Sachs Group Inc. | |
| 31.10.24 | Santander Buy | Goldman Sachs Group Inc. | |
| 31.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.10.24 | TotalEnergies Buy | UBS AG | |
| 31.10.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 31.10.24 | AXA Buy | UBS AG | |
| 31.10.24 | GSK Neutral | UBS AG | |
| 31.10.24 | ING Group Buy | UBS AG | |
| 31.10.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 31.10.24 | TotalEnergies Hold | Jefferies & Company Inc. | |
| 31.10.24 | BBVA Buy | Jefferies & Company Inc. | |
| 31.10.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 31.10.24 | ING Group Sector Perform | RBC Capital Markets | |
| 31.10.24 | Siemens Outperform | RBC Capital Markets | |
| 31.10.24 | BBVA Outperform | RBC Capital Markets | |
| 31.10.24 | Siemens Buy | Jefferies & Company Inc. | |
| 31.10.24 | Santander Sector Perform | RBC Capital Markets | |
| 31.10.24 | UBS Outperform | RBC Capital Markets | |
| 31.10.24 | AXA Overweight | JP Morgan Chase & Co. | |
| 31.10.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 31.10.24 | Siemens Overweight | JP Morgan Chase & Co. | |
| 31.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.10.24 | Mercedes-Benz Group (ex Daimler) Buy | Jefferies & Company Inc. | |
| 30.10.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 30.10.24 | BP Buy | UBS AG | |
| 30.10.24 | GSK Neutral | UBS AG | |
| 30.10.24 | Novartis Outperform | Bernstein Research | |
| 30.10.24 | HSBC Buy | Deutsche Bank AG | |
| 30.10.24 | Santander Buy | Deutsche Bank AG | |
| 30.10.24 | Novartis Hold | Deutsche Bank AG | |
| 30.10.24 | GSK Outperform | Bernstein Research | |
| 30.10.24 | Philips Hold | Deutsche Bank AG | |
| 30.10.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 30.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.10.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 30.10.24 | UBS Outperform | RBC Capital Markets | |
| 30.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.10.24 | Deutsche Telekom Overweight | JP Morgan Chase & Co. |